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Abstract 
 
Radiotherapy and surgery are the two principal modalities in the treatment of head 
and neck cancers, and both therapies can result in severe adverse effects and ultimately 
lower the quality of life.  It is of paramount importance to develop reagents that target the 
cancer cell specifically without affecting the normal non-cancer cells. Using the tongue 
cancer cell line Cal 27 as a model system, we dissected the molecular mechanism of the 
resveratrol-induced cancer cell apoptosis. After demonstrating that resveratrol induces the 
cancer cell apoptosis in a dose- and time-dependent manner, a systemic apoptosis protein 
array was conducted to identify the resveratrol-induced proteins pertinent to the apoptotic 
pathways.  Ten of the 43 proteins included in the array were up- or down-regulated by 
resveratrol by about 50 percent. Finally, the activation of caspase-3 and the cleavage of 
PARP in resveratrol-induced apoptotic cells were confirmed by western blot.  We 
postulate resveratrol induces apoptosis in Cal-27 cells which will render the cells from 
being able to repair double-stranded-break in the DNA as both P53 and P21 will be up 
regulated and thus leading to senesce of the cell replication, suggesting that resveratrol 
could potentially serve as a chemo-preventive reagent. 
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Introduction 
Cancer is the second most common cause of death in the US, exceeded only by 
heart disease, and accounting for nearly 1 of every 4 deaths. In the United States this year 
nearly 2 million people will be diagnosed with cancer and ½ million people, or about 
1500 people a day, will die from it.  Head and neck cancers make up about 3-5 percent of 
all cancers (Howlader et al., 2013). Head and neck cancer is the sixth most common 
neoplasm worldwide with over half million new cases reported each year (Jemal, Siegel 
Ward, 2008) and head and neck squamous cell carcinoma (HNSCC) is most prevalent.  
The American Cancer Society approximates that each year there are 28,500 new cases of 
oral cavity and oropharyngeal cancers in the United States. Of these new cases, an 
estimated 6,100 will result in mortality.  The 5-year survival rate, in all genders and races 
and at all stages, is only 60 percent. After spreading, the survival rates of regional and 
metastasized cancers drop to 51.8 and 27.8 percent, respectively (Kademani, 2007).  
Oral cavity and oropharyngeal cancers occur most commonly in the tongue 
(approximately 25% of cases), followed by the tonsils, the lip or the minor salivary 
glands (each approximately 10% - 15% of cases). The rest are found in the gums, the 
floor of the mouth, and other sites.  Interestingly, 15% of patients who are newly 
diagnosed with oral and oropharyngeal cancers will also have another cancer in a nearby 
area such as the larynx, the esophagus, or the lung upon further examination. Of those 
who are cured of their oral or oropharyngeal cancer, 10% - 40% will develop 
abovementioned cancers at a later time (Epstein, Gorsky, Cabay, Day, & Gonsalves, 
2008).  
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In general, head and neck cancers encompass a diverse group of uncommon 
tumors that frequently are aggressive in their biologic behavior. Thus, detection of oral 
cancers is critically important, because advanced tumors require more aggressive therapy. 
However, diagnosis and treatment of oral cancers are particularly difficult tasks due to 
the sheer aggressiveness of these cancers and the fact that despite improvements in 
surgical and radiation techniques, as well as advances in chemotherapy, the 5-year 
survival rates for these patients are still only 50%. Half of the patients afflicted with these 
cancers are expected to die within the first two years of diagnosis (Bankfalvi & Piffko, 
2000). Making the situation even more difficult is the fact that a significant increase in 
the incidence of oral cancer and its mortality has been observed over the last several 
decades, with a striking upward trend in younger males, especially in some eastern and 
central European countries (Soleas, Diamandis, & Goldberg, 1997). Thus, oral cancer is 
expected to be one of the significant public health problems in the foreseeable future 
(Bankfalvi & Piffko, 2000). 
There are many complications that may arise when traditional therapeutic 
treatments are used and as expected more intensive therapeutic approaches utilized to 
improve survival among patients also increase complications. Radiotherapy and surgery 
are the two principal modalities in treatment of HNSCC, but both result in significant 
side effects which ultimately affect the quality of life of the patients. For example, 
radiation can induce unavoidable changes in surrounding normal tissues compromising 
immune function. Mucocutaneous changes as a result of irradiation can lead to hair loss 
and mucositis.  Taste buds are included in the direct beam of radiation used for most oral 
cancers, making them especially sensitive to irradiation, and as a result most patients will 
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develop a partial or, more typically, complete loss of taste during treatment. Salivary 
function is also lost when major salivary glands are exposed to ionizing radiation. This 
combination of loss of taste and salivary function can have a detrimental effect on a 
patient’s nutrition. Resultant weight loss can lead to weakness, further anorexia, and 
susceptibility to infection. Lack of saliva and/or changes in the chemical composition of 
saliva can cause dental caries and tooth decay.  The direct irradiation of teeth may also 
alter organic and inorganic components of the teeth making them more susceptible to 
decalcification and lead to dental caries.  Infections of the mouth by Candida albicans are 
seen commonly in irradiated patients and are also related to alterations in saliva. One of 
the more serious complications of irradiation of the head and neck is osteonecrosis. Bone 
cells and vascularity may be irreversibly injured leading to intolerable pain or fracture 
and may even necessitate jaw resection. Chemotherapy alone is not an effective treatment 
for oral cancers, although some regimens can enhance radiation and surgery. The toxic 
effects of chemotherapy are usually acute and may add to the morbidity of treatment. 
Therefore, treatment must often strike a balance between the adverse side effects of 
chemotherapy and the benefits of increasing response and survival (Kademani, 2007). 
Preventing or at least minimizing these complications is vital to not only successful 
rehabilitation, but also, quality of life. Efforts to explore innovative mechanism-based 
targets and approaches for the management of cancer are currently ongoing. 
Chemoprevention and treatment via ingestion of natural or synthetic agents with 
low toxicity that are able to suppress, delay, or reverse carcinogenesis, is being 
considered as a new dimension in the management of cancer.  One of these agents, 
resveratrol (3, 4', 5-trihydroxystilbene), belongs to a class of polyphenolic compounds 
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called stilbenes (Soleas et al., 1997).  It is a phytoestrogen present in the skin of red 
grapes and various other food products, with structural similarity to estradiol and 
diethylstilbestrol (Siemann & Creasey, 1992). Some types of plants produce resveratrol 
and other stilbenes in response to stress, injury, fungal infection, or ultraviolet radiation 
(Aggarwal et al., 2004).  Plants that produce resveratrol include spruce (picea sp), pine 
(pinus sylvestris), cranberry (vaccinum sp), mulberry (morus rubra), grapes (vitis 
vinifera), and peanuts (arachis hypgea). Resveratrol is a fat-soluble compound that occurs 
in both trans- and cis-configurations (Figure 1). In the recent past, trans-resveratrol has 
been shown to inhibit cancer initiation, promotion, and progression (Aziz, Nihal, Fu, 
Jarrard, & Ahmad, 2006). Studies have shown that each gram of fresh red grape skin 
contains 50 to 100μg of resveratrol, and its concentration in red wine ranges from 10 to 
20μmol/L (Jang et al., 1997). Consequently, resveratrol is being considered as an 
excellent candidate agent for cancer treatment and chemoprevention (Aggarwal et al., 
2004).  
 
Figure  1- Chemical structures of cis-((Z)-resveratrol, left) and trans-resveratrol ((E)-resveratrol, right) 
 
                          
Scientists became more interested in exploring potential health benefits of 
resveratrol in 1992 when its presence was first reported in red wine, leading to 
speculation that resveratrol might help explain the “French Paradox” - the observation 
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that people from France suffer a relatively low incidence of coronary heart disease, 
despite having a diet relatively rich in saturated fats (Bankfalvi & Piffko, 2000). As a 
phenolic compound, resveratrol contributes to the antioxidant potential of red wine and 
may play a role in the prevention of human cardiovascular diseases. Resveratrol has been 
shown to modulate the metabolism of lipids and to inhibit the oxidation of low density 
lipoproteins (LDL) and the aggregation of platelets (Bankfalvi & Piffko, 2000). Changes 
in LDL properties by oxidation of polyunsaturated fatty acids (PUFA) are believed to 
play a major role in atherosclerosis.  
Furthermore, resveratrol obtained from Cussia quinquangulutu (Leguminosae) 
had a cancer chemopreventive activity in assays representing the three major stages of 
carcinogenesis (Wilson, Roberts, & Deeley, 1997). It acted as an antioxidant and anti-
mutagen and induced the detoxification of carcinogens. It also mediated anti-
inflammatory processes mainly by inhibiting cyclooxygenase-1 (COX-1) and 
hydroperoxidase functions. Resveratrol also inhibited the progression of cancer by 
inducing cell differentiation. Direct evidence of the chemopreventive activity of 
resveratrol was assessed by its ability to inhibit the development of preneoplastic lesions 
in carcinogen-treated mouse mammary glands in culture as well as tumorigenesis in a 
mouse skin cancer model. Likewise, resveratrol inhibited the cellular processes involved 
in the three stages of tumor development (Wilson et al., 1997). The authors compared the 
effect of resveratrol in three human breast epithelial cells (immortal estrogen receptor-
negative and malignant estrogen receptor-negative or receptor-positive). With each line, 
the inhibition of proliferation was both dose- and time-dependent. Moreover, treatment 
with resveratrol reduced the number of viable cells and prevented the exponential growth. 
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This suggested that resveratrol is a potential chemotherapeutic agent for both hormone-
responsive and non-responsive breast cancers. Because cyclooxygenase-2 (COX-2) is 
important for tumorigenesis, the ability of resveratrol to modulate the gene expression of 
this enzyme was investigated in human mammary and oral epithelial cells (Wilson et al., 
1997).  Unlike normal cells, cancer cells proliferate rapidly and are unable to respond to 
cell death signals that initiate apoptosis. Resveratrol has been found to inhibit 
proliferation and induce apoptosis in a number of cancer cell lines including prostate 
cancer (Khan, Adhami, & Mukhtar, 2010), colon cancer (Trincheri, Nicotra, Follo, 
Castino, & Isidoro, 2007), breast cancer (Sareen, Darjatmoko, Albert, & Polans, 2007), 
and lung cancer (Whyte, Huang, Torres, & Mehta, 2007). However, the anti-cancer 
effects of resveratrol on human oral cancer cells have not been well established (Aziz et 
al., 2006). Furthermore, the protein targets that resveratrol induces to cause apoptosis in 
oral cancer cells have not been established. Protein targeted therapy is on the forefront of 
treatment for various diseases like Hodgkin’s disease and colon cancer among others, 
thus establishing the proteins targeted by RSV on oral cancer cells has become more 
important.  
Apoptosis is a recognized mechanism of controlled cell deletion, which appears to 
play a complementary but opposite role to mitosis in the regulation of animal cell 
populations. Apoptosis is a vital process in a wide variety of different biological systems, 
including normal cell turnover, the immune system, embryonic development, 
metamorphosis and hormone dependent atrophy, and also in chemical-induced cell death. 
Apoptotic cell death occurs in two phases: First, a commitment to cell death, and second, 
an execution phase that is characterized by stereotypic morphological changes in cell 
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structure, suggesting the presence in different cells of common execution machinery. It 
affects individual cells and does not induce an inflammatory response. Some 
morphological changes associated with apoptosis include cell shrinking, cell shape 
change, condensation of the cytoplasm, nuclear fragmentation, and cell detachment. 
Some of the functional/biochemical changes include bcl2/bax interaction and DNA 
denaturing (Kerr, Wyllie, & Currie, 1972).   Its morphological features suggest that it is 
an active, inherently programmed phenomenon, and it has been shown that it can be 
initiated or inhibited by a variety of environmental stimuli, both physiological and 
pathological. The structural changes occurring in apoptosis take place in two discrete 
stages. The first comprises nuclear and cytoplasmic condensation and breaking up of the 
cell into a number of membrane-bound, ultrastructurally well-preserved fragments. In the 
second stage, these apoptotic bodies are shed from epithelial-lined surfaces or are taken 
up by other cells, where they undergo a series of changes resembling in vitro autolysis 
within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the 
ingesting cells. Apoptosis seems to be involved in cell turnover in many healthy adult 
tissues and is responsible for focal elimination of cells during normal embryonic 
development. It is implicated in both physiological involution and atrophy of various 
tissues and organs. It also occurs spontaneously in untreated malignant neoplasms and 
participates in at least some types of therapeutically induced tumor regression. It can 
additionally be triggered by noxious agents, both in the embryo and adult animal (KERR 
et al., 1972). Inappropriate apoptosis is implicated in many human diseases, including 
neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, ischemic 
damage, autoimmune disorders and several forms of cancer (Cohen, 1997). 
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There are other signs that apoptosis is taking place and can be detected using 
various techniques for example, cleavage of Poly (ADP-ribose) polymerase by caspase. 
Not only are cleaved products of PARP detectable, but cleaved proteins of the 
executioner protein called caspase are also detectable. Poly (ADP-ribose) polymerase 
(PARP-1) is a nuclear enzyme that catalyzes the transfer of ADP-ribose polymers onto 
itself and other nuclear proteins in response to DNA strand breaks. PARP assists in the 
repair of single-strand DNA nicks. It binds sites with single strand breaks through its N-
terminal and will recruit DNA ligase III, DNA polymerase beta and a kinase to the nick, 
in the process of base excision repair (BER). PARP-2 has been shown to oligomerize 
with PARP-1 and therefore is also implicated in BER. The oligomerization has also been 
shown to stimulate PARP catalytic activity. PARP-1 is also known for its role in 
transcription through remodeling of chromatin by PARylating histones and relaxing 
chromatin structure, thus allowing transcription complex to access genes (Cohen, 1997).  
PARP-1, a 116 kDa nuclear enzyme, is cleaved in fragments of 89 and 24 kDa 
during apoptosis. This cleavage has become a useful hallmark of apoptosis. PARP-1 is 
also processed during necrosis but a major fragment of 50 kDa is observed instead. 
According to Gobeil, et al, the cleavage products of PARP will depend on the substance 
that is causing the apoptosis (Gobeil, Boucher, Nadeau, & Poirier, 2001). In response to 
DNA damage induced by ionizing radiation, oxidative stress and DNA-binding antitumor 
drugs, PARPs enzymes add ADP-ribose units to carboxylate groups of aspartic and 
glutamic residues of target proteins. This poly (ADP ribosylation) activity of PARPs is a 
post-translational modification that triggers the inactivation of the acceptor protein 
through the attachment of a complex branched polymer of ADP-ribose units (Cepeda et 
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al., 2006). In order for apoptosis to take place, the zymogen form of caspase must be 
activated in order to start cleaving parts of the cell and cause apoptosis.    
Induction of apoptosis via death receptors typically results in the activation of an 
initiator caspase such as caspase 8 or caspase 10. These caspases can then activate other 
caspases in a cascade. This cascade eventually leads to the activation of the effector 
caspases, such as caspase 3 and caspase 6, which are responsible for the cleavage of the 
key cellular proteins, such as cytoskeletal proteins, that leads to the typical morphological 
changes observed in cells undergoing apoptosis. There are a number of other 
mechanisms, aside from activation of the death receptors, through which the caspase 
cascade can be activated. Granzyme B can be delivered into cells by cytotoxic T 
lymphocytes and is able to directly activate caspases 3, 7, 8 and 10. The mitochondria are 
also key regulators of the caspase cascade and apoptosis. Release of cytochrome c from 
mitochondria can lead to the activation of caspase 9, and then of caspase 3. This effect is 
mediated through the formation of an apoptosome, a multi-protein complex consisting of 
cytochrome C, Apaf-1, pro-caspase 9 and ATP. One of the hallmarks of apoptosis is the 
cleavage of chromosomal DNA into nucleosomal units. The caspases play an important 
role in this process by activating DNases, inhibiting DNA repair enzymes and breaking 
down structural proteins in the nucleus. The enzyme PARP was one of the first proteins 
identified as a substrate for caspases. PARP is involved in repair of DNA damage and 
functions by catalyzing the synthesis of poly (ADP-ribose) and by binding to DNA strand 
breaks and modifying nuclear proteins. The ability of PARP to repair DNA damage is 
prevented following cleavage of PARP by caspase-3. Caspase-3 is one of the key 
executioners of apoptosis, being responsible either partially or totally for the proteolytic 
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cleavage of many key proteins, such as the nuclear enzyme poly (ADPribose) polymerase 
(PARP), which are cleaved in many different systems during apoptosis (Cohen, 1997).  
It has been shown by Attar, et.al that resveratrol did cause cell proliferation 
inhibition as well as DNA synthesis inhibition, of an oral squamous cell cancer line 
called SCC-25 cells (El Attar & Virji, 1999). However, Attar et.al did not look at 
apoptosis, or more generally the mechanisms for this inhibition of proliferation of the 
SCC-25 cells.  The SCC-25 cell line is derived from a squamous cell cancer and like 
other oral cancer cell lines behave very differently from one another. Most tissues within 
the oral and oropharyngeal cavity have properties of both squamous and gland-like 
tissues. For example, studies have shown Cal 27 xenographs to be adenosquamous in 
nature, thus, this cell line would be a better representative for oral cancer than squamous 
cell cancer cell line. Studying the Cal-27 cells will aid in finding a cell line that is more 
representative of oral cancers (Jiang et al., 2009).   
Cal27 cell line seems to be a better lineage to investigate the effects of resveratrol 
for inducing apoptosis. These cells were derived in 1983 from the tumor tissue of a 
56 year old Caucasian male with poorly differentiated adenosquamous cell carcinoma at 
the middle of the tongue. Gioanni et al experimented with the Cal 27 cells and found that 
the doubling time was about 35 hours.  These cells were tumorigenic in nude mice.  They 
concluded that the behavior of this cell line in the nude mice and in cultures is similar to 
that of the original cancers from which it was derived (Gioanni et al., 1988).  However, 
due to variable growth patterns and responses to cytoxicity, the development of an 
encompassing OSCC model cell line has been challenging.  This has presented as a 
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difficulty to clinicians and has called for the development of more personalized therapies 
for decades (Gioanni et al., 1988).  Therefore, until a strong OSCC model cell line can be 
established, studying resveratrol effects on OSCC lines for the purpose of clinical 
treatment will have to be approached sequentially, investigating smaller subsets or cell 
lineages individually (El Attar & Virji, 1999).  
The focus of this study is using the Cal 27 cell line as a model for oral cancer to 
determine which protein factors are up regulated and down regulated with the treatment 
of resveratrol.  Understanding that quality of life can be drastically diminished using the 
standard treatments for oral cancer, it is of critical importance to find a means of effective 
treatment for this cancer that does not reduce the quality of a patient’s life dramatically. 
Removing or damaging parts of the oral cavity due to cancer and or treatment may 
impact a patient’s health, self-image, and cause them to lose their primary means of 
communication. We know that resveratrol is a natural compound found in many plants 
and has been used in multiple in vitro and in vivo studies to treat many cancers including, 
prostate, colorectal, breast, lung, and skin (Anand et al., 2008). If we can show that 
resveratrol can, not only prevent oral cancer cell proliferation, but by also regulating 
specific proteins in Cal 27 cells, we can continue to add to the data base of oral cancer 
cell lines that are susceptible to RSV and eventually find a cell line that will become the 
ideal model to study oral cancers.  Many papers have shown that resveratrol works 
through the mechanism of apoptosis.  As stated earlier we chose Cal 27 cells because 
Gioanni et al, have described these cells a ‘good model for in vitro oral cancer studies’ 
based on doubling time, cell survival, and its response to treatment. Thus, we have 
chosen to look for conclusive protein markers of apoptosis on Cal 27 cells after they have 
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been treated with resveratrol. The markers we chose are caspase and poly-ADP ribose 
polymerase (PARP). In a non-apoptotic cell, PARP protein will be at a baseline level 
working to repair anything incorrect in the cell. PARP detects and then signals single-
strand DNA breaks (SSB) to the enzymatic machinery involved in the SSB repair. PARP 
activation is an immediate cellular response to metabolic, chemical, or radiation-induced 
DNA SSB damage. Once PARP detects a SSB, it binds to the DNA, and, after a 
structural change, begins the synthesis of a poly (ADP-ribose) chain as a signal for the 
other DNA-repairing enzymes such as DNA ligase III, DNA polymerase beta, and 
scaffolding proteins such as X-ray cross-complementing gene 1 (XRCC1) (Gobeil, 
Boucher, Nadeau, & Poirier, 2001).  However, it is shown that apoptosis works by 
cleaving this protein, so it does not interfere with cell death.  When a cell is going 
through apoptosis, we can detect cleaved products of the PARP protein. Bcl-2 protein is 
the prototype for a family of mammalian genes and the proteins they produce. They 
govern mitochondria outer membrane permeabilization (MOMP) and can be either pro-
apoptotic (Bax, BAD, Bak among others) or anti-apoptotic (including Bcl-2 proper, BCL-
xl, Bcl-w among an assortment of others) (Cepeda et al., 2006). When a cell is going 
through apoptosis, an increase or decrease of various markers can be detected.  
Depending on the cell line, resveratrol can take an intrinsic or extrinsic pathway 
of apoptosis (Cohen, 1997). We conducted an assay with the human apoptosis marker kit 
to show various apoptotic proteins i.e. PARP, BCl-2, and caspase that are either 
upregulated or downregulated with the presence of resveratrol. We also attempted to look 
for morphological changes in the cell such as loss of cell membrane integrity by looking 
for annexin V binding protein, a marker for this process. Finally, we tried to further 
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substantiate the apoptosis assay by Western blot analysis. Using the information we 
gained with the model of tongue carcinoma, we hope to show that resveratrol induces 
apoptosis while further elucidating its protein pathway of action. Finally, studies using 
this model for oral cancer may add another piece of information about treating oral 
cancer with a safe and natural compound.   
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Materials and Methods 
 
Chemical reagents and cell lines 
 
Resveratrol was purchased from Sigma (St. Louis, MO) and a stock solution (200 
mM) was made by dissolving RSV in alcohol and stored at -20
o
C.  The CAL 27 cell line 
was obtained from American Type Culture Collection cells were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) with 10 percent fetal bovine serum and 1 
percent antibiotics at 37°C and 4% CO2.  We used antibiotic-antimycotic (100X) from 
GIBO (cat 15240). This antibiotic contains 10,000 units of penicillin (base), 10,000 µg of 
streptomycin (base), and 25 µg of amphotericin B/ml utilizing penicillin G (sodium salt), 
streptomycin sulfate, and amphotericin B as Fungizone® Antimycotic in 0.85% saline.  
The cells were cultured in an incubator at 37°C with 4% CO2 (abcam, 2013).  
Addition of 1x 10
6 
cells were plated and would equal approximately 70% 
confluency within 24 hours. We treated the cells with resveratrol at this confluency, as it 
allowed for adequate time for the cells to fully take up the resveratrol. As the cells 
divided, the effects of resveratrol could be visualized.  Cells were collected at different 
time points allowing for observation of the effects of resveratrol with varying amounts of 
time. Cells needed to be sub-cultured after 90 percent confluency was achieved because 
after this point, cells start dying on their own and, thus we would be unable to 
differentiate cell death due to resveratrol versus cell death due to stress. 
 Cell lysate preparation, western blot and antibodies 
After treating the cells with resveratrol we incubated them for 2, 6, 24 and 48 
hours to determine the amount of time it took for resveratrol to affect the cells. To make 
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whole cell lysate, cells were washed with cold phosphate-buffered saline (PBS) twice and 
lysed with EBC Buffer (20 mM Tris-HCl, pH 8.0, 125 mM EDTA and 0.5% NP-40) with 
proteinase inhibitors. A freeze thaw cycle was done 3 times to induce physical and 
compositional changes in the cell membranes (Borochov, Walker, Kendall, Pauls, & 
McKersie, 1987). These compositional changes cause more protein to leak out of the 
membrane and this can be quantified. Cell debris was removed by high speed 
centrifugation and lysates were stored at -20
o
C.  Protein concentrations were estimated 
using the Thermo Scientific Pierce BCA Protein Assay kit. The purple-colored reaction 
product of this assay is formed by the chelation of two molecules of BCA with one 
cuprous ion. This water-soluble complex exhibits a strong absorbance at 562 nm that is 
linear with increasing protein concentrations over a broad working range (20-2,000 
μg/ml). The protein concentrations in cell lysate were inferred from the standard curve 
(ThermoScientific, 2012) and equal amounts of total proteins (50 µg) loaded into wells in 
the gel. One lane was reserved for a marker/ladder, a mixture of proteins having defined 
molecular weights, typically stained so as to form visible, colored bands. Once the 
samples were loaded, they were separated on a 10% SDS-PAGE gel.  We used the 
“iBlot”dry blotting transfer method. This system blots proteins from polyacrylamide gels 
in 7 minutes without the need for additional buffers.  The “iBlot” device uses disposable 
blotting stacks with integrated nitrocellulose membranes. The bottom stack includes a 0.2 
µm nitrocellulose membrane (Life Technologies Corporation, 2013).  Blots were blocked 
for 2 hours in 5% non-fat milk and incubated with antiserum overnight at 4
o
C.   After 
washing three times in TBST, the blot was incubated with the secondary antibody 
conjugated with HRP and detected by Supersignal West Pico Chemiluminescent Kit 
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(Pierce).  The same membranes were stripped and re-probed for either β-actin or GAPDH 
as internal controls.  Western blot provides information about the size of proteins (with 
comparison to a size marker or ladder in kDa), and protein expression (with comparison 
to a control such as untreated sample or another cell type or tissue).  The antibodies 
against Caspase-3 and PARP were purchased from Cell Signaling Technology, Inc 
(Cat#9452, Danvers, MA).  This antibody specifically attached to the protein we were 
looking for.  
Initially, the antibody was used in equal parts milk and TBST, which has a small 
amount of detergent called tween 20, and let it incubate overnight. We eventually 
changed to using caspin, the agent in milk responsible for the blocking when mixed with 
PBS.  The primary antibody, which is the specific antibody mentioned above, attached to 
the protein and formed an antibody-protein complex with the protein of interest. After 
overnight incubation, we took the blot out of the primary antibody, and washed it with 
TBST for 30 minutes. We put the secondary antibody in caspin or milk. The secondary 
anti-body was an antibody-enzyme conjugate. The secondary antibody was an antibody 
against the primary antibody. The conjugated enzyme allowed visualization of the 
complex. Finally, to see the enzyme, we incubated the blot it in a reaction mix called 
SuperSignal West Pico Chemiluminescent from Thermo Scientific (lot #KK139345A). If 
everything worked properly, we saw bands wherever there was a protein-primary 
antibody-secondary antibody-enzyme complex, or, in other words, wherever the protein 
was.  
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Annexin V-FITC assay  
The Annexin V-FITC fluorescence Microscopic Kit (51-8074KC) was purchased 
from BD Biosciences Pharmingen (San Jose, CA). The assay was conducted according to 
the manufacturer’s instruction.  Briefly, 1x106 cells were seeded to the 4 well chamber 
slide system and incubated for 12 hours to adhere the cells to the plate before different 
concentrations of RSV (0μm, 10μM, 25μM, 50μM and 100μM) were added and 
incubated for 24 or 48 hours. Cells were wash twice with 1X PBS and stained with 
Annexin V-FITC (diluted 1:10 in 1X Annexin V Binding Buffer) for 15 min at Room 
temperature.  Cells were washed with 1X Binding Buffer and visualized under light and 
florescence microscope.   
 
Apoptosis antibody array  
The Human Apoptosis Antibody Array Kit (Cat# AAH-APO-1-2) was purchased from 
the RayBiotech, Inc. (Norcross, GA) and the assay was conducted according to the 
manufacturer’s instruction. In our experiment, two sets of Cal-27 cells, (approximately 
1x10
6
 cells) were plated and one plate was treated with 200μM of resveratrol for 24 hours 
and the other was the control.  Briefly, the control or RSV-treated CAL 27 cells were 
lysed in 1 x Lysis Buffer provided by the kit with addition of protease inhibitors.  Lysates 
containing about 200μg total proteins were incubated with the array membranes over 
nigh at 4
o
C with gentle agitation.  After washing twice with 1x Washing Buffer, the 
membranes were incubated with the Cocktail of Biotin-Conjugated Antibody Mix 
overnight at 4
o
C with gentle agitation, followed by 1.5 hours incubation with the HRP-
conjugated Streptavidin  at room temperature. Finally, the signals were detected when the 
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chemiluminescence substrates were added and visualized by exposing to the X-ray films. 
The intensities of each array dot were quantified by using the Gel-Pro Imager and 
normalized against the internal control. Antibody affinity to its target varies significantly 
between antibodies. The intensity detected on the array with each antibody depends on 
this affinity; therefore, signal intensity comparison can be performed only within the 
same antibody/antigen system and not between different antibodies (RayBio, 2011).   
The Human Apoptosis Antibody Array kit allows for a concurrent detection of the 
relative levels of 43 apoptosis related proteins in cell lysates. By monitoring the changes 
in protein levels in different experiments, we can study pathway activation. By doing this 
experiment, we know exactly which apoptosis protein is the highest in our cell and we 
can focus on that protein to do all our experiment without spending excess time and effort 
in performing Western Blotting for random apoptosis proteins that may or may not be 
showing in our cell.  
 
 
Chart 1a Antibody array map showing all 43 apoptosis protein markers. This can be used to correlate 
specific densities matching specific proteins. As can be seen, there are positive and negative controls that 
are used to normalize the density and thus, negate any variations in exposure.     
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Results 
 
Effects of RSV on tongue cancer cell CAL 27 proliferation 
The general theme of RSV’s effects is inhibiting cancer cell growth and 
enhancing apoptosis (Meeran, Akhtar, Katiyar, 2009).  To determine the effects of RSV 
on oral cancer cells, we first treated the Cal 27 cells with different concentrations of RSV 
for different periods.  The number of cells in the control (0μM RSV) was set as 100% and 
the numbers of cells treated with different RSV concentrations (0 to 200μM) were 
expressed as percentage of the control (Graph 1a). It is demonstrated that the effects of 
RSV on Cal 27 cell growth and/or apoptosis are dose-dependent and this is consistent 
with previous reports (Wang, Hudson, Remsberg 2010). Since 25μM of RSV was able to 
inhibit cell proliferation by more than 50%, we conducted a refined inhibition assay 
(Graph 1b) and shown that RSV inhibited CAL 27 growth in a dose- and time-dependent 
manner.   
 
Figure 1a. 5 plates of Cal 27 cells were treated with 25, 50, 100, 200 uM of resveratrol and cells were 
counted after 24 hours. As the concentration of resveratrol increased, the relative number of cells 
decreased. This experiment was done in triplicates, and the error bars show variance in the number of cells 
and the bars show the average of the three plates. 
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Figure 1b.  2 plates of Cal 27 cells were treated with 12 uM and 25 uM of resveratrol over a period of 60 
hours in triplicates. The control group was not treated. This shows both a time and dose dependent effect of 
resveratrol as well the variance in the number of cells represented by error bars. 
 
RSV induces apoptosis in CAL27 cells 
The loss of plasma asymmetry is a key feature of apoptosis. In normal cells, 
membrane phospholipids are distributed asymmetrically between the inner and outer 
leaflets of the plasma membrane. For example, phosphatidylserine (PS), an 
aminophospholipid, is normally present in the inner leaflet (on the cytosolic side) of the 
plasma membrane. In the early stages of apoptosis changes occur at the cell surface. One 
of these plasma membrane alterations is the translocation of (PS) from the inner side of 
the plasma membrane to the outer layer exposing it at the external surface of the cell. 
Annexin V, a 35-36 kDa, calcium-dependent, phospholipid-binding protein with a high 
affinity for PS, is used to indirectly monitor PS translocation. Hence, this protein can be 
used as a sensitive probe for PS exposure upon the cell membrane. We used annexin V 
labeling in order to test for this loss of cell membrane integrity after we added resveratrol 
(RSV) to the Cal-27 cells. When PS translocates to the outer surface of the cell 
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membrane, a fluorchrome attached annexin V protein binds to the PS. Thus, one can use 
FITC-annexin V and flow cytometry, to identify the population of cells with membrane 
changes and associated loss of membrane integrity of Cal-27 cells. In normal, healthy 
cells there is no such translocation of PS and thus, annexin protein cannot bind and 
cannot be visualized. In this experiment, we were able to visualize time- and dose-
dependent effects of RSV on Cal -27 cells. The fluorescence image of the cell membrane 
shows the annexin V binding to the PS in the subpopulation of the cells going through 
apoptosis.  As seen in the Figure 2a and 2b, the cells that did not receive treatment with 
RSV did not show any significant fluorescence, suggesting that apoptosis was not 
occurring.  
 Results in figure 2a show that cells started undergoing apoptosis at 25uM 
concentration, bright green indicates that a considerable amount of PS had translocated to 
the outer surface of the membrane. Looking at the light microscope picture, we can see 
an intact cell membrane, differentiating it from the process of necrosis, where the cell 
membrane will have been torn.   The amount of Annexin V-FITC positive cells and the 
cell morphology can vary according to the cell type, model system, treatment type, or 
time after apoptosis induction. 
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Figure 2a 
This panel shows Cal-27 cells collected at 3 hours after treatment with (from the top to bottom): 0, 25, 50, 
100, 200uM RSV. On the Left: Cal-27 clusters visualized through a light microscope. On the Right; the 
same cluster of cells visualized with the flow cytometer. The top panel, which was the control, had no 
florescence. However, as the concentration of resveratrol increased, the florescence also increased 
indicating that the cell membrane integrity of many of the cells has been lost. The last panel show a cluster 
of cells growing very close to each other, with certain cells growing on top of each other. 
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Figure 2b 
This panel shows Cal-27 cells collected at 24 hours after treatment with (from the top to bottom): 0, 25, 50, 
100, 200uM RSV. On the Left: Cal-27 clusters visualized through a light microscope. On the Right; the 
same cluster of cells visualized with the flow cytometer. The top panel, which was the control, had no 
florescence. However, as the concentration of resveratrol increased, the florescence also increased 
indicating that the cell membrane integrity of many of the cells has been lost. The last panel show a cluster 
of cells growing very close to each other, with certain cells growing on top of each other. 
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RSV effects on levels of protein in the apoptotic pathway 
As we can see from Figure 3, which was adopted from Murphy, et.al, 2008, there 
are various pathways for the cell to go through apoptosis.  The final step of apoptosis is 
proteolysis of pro-caspase-3 into activated caspase-3 which will cause irreversible 
changes to PARP, which subsequently will lead to DNA nicking and cell death. As seen 
in the figure, there are multiple pathways and enzymes that are either working to keep the 
cell alive or to cause cell death. As the balance changes either in cell proliferation or cell 
death, certain proteins and pathways are upregulated and others are downregulated.   
 
 
Figure 3. This figure is adopted from Murphy et,al.  represents a cell, including the extracellular space, 
cytoplasm, and nucleus of the cell. Poly (ADP-ribose) polymerase (PARP) is a family of proteins involved 
in DNA repair.  Caspase-3 is the executioner caspase and once activated through one of various pathways, 
it translocates from the cytoplasm into the nucleus and cleaves PARP leaving the cell without one of the 
most important mechanism to protect and repair itself, leading to apoptosis (Murphy, Perry, & Lawler, 
2008). 
 
Before further studying the mechanisms of RSV-induced CAL 27 cell apoptosis, 
we choose to conduct a systemic search of RSV-induced expression of different protein 
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factors in the apoptotic pathways.  We took advantage of the availability of the Human 
Apoptosis Antibody Array Kit (Ray Bio) which allows a concurrent detection of the 
relative levels of 43 well established apoptosis-related proteins in cell lysates. The result 
is displayed in Figure 4. A computer program (Gel Pro Imager) was used to determine the 
relative densities of each protein by normalizing to the controls on each membrane.   
 
 
Figure 4. This is the membrane that the proteins have attached to. The highlighted proteins are an example 
of how each density is related to its protein. The antibodies attach to their respective proteins in duplicates.  
Using a computer program (Gel Pro-Imager), the relative densities were quantified and normalized to the 
controls for each membrane. 
 
  In order to find the changes of as many proteins as possible, we choose to treat 
the CAL 27 cells with high concentration of RSV (200μM) for long period (24 hour) of 
time.  Among the 43 protein factors included in the array, 10 (caspase-8, CD-40, CD-
40L, HSP-70, IGF-II, p21, p53, SMAC, survivin, and XIAP) of them showed changes 
(~50 percent change). RSV effect on Cal-27 cells not only upregulated the pro-apoptosis 
markers such as, SMAC, caspase-8, p21, p53, but it also downregulated the cell survival 
protiens such as survivin, CD40 and CD40L. 
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In order to better understand the effects of RSV on CAL 27 cell apoptosis, we 
categorized the 43 proteins in the array into groups as shown in Chart 1a. As we can see 
in Graph 2a, Caspase 8 was the most induced factor (more than 3 folds) by RSV.  It is 
well known that Caspase-8 is a member of cysteine-aspartic acid protease family and an 
initiator caspase that activates executioner caspases (i.e. caspase-3 and caspase-6).  On 
the other hand, both Cd40 and Cd40L were significantly down-regulated by RSV 
treatment.  It has been shown that interaction of CD40 receptors with their ligand CD40L 
can reduce apoptosis through a caspase-3-dependent mechanism.  The interaction 
between CD40 and CD40L also promote survival by preventing the release of 
cytochrome-c from the mitochondria and thus prevent the intrinsic apoptotic pathway.   
 
Graph 2a In this panel, Caspase 8, Cd40 and Cd40L (~50 % unit) change. 
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Heat shock proteins are a family of ubiquitously expressed proteins compromising 
important machinery for protein folding and protection of cells from stresses.  Heat shock 
protein-70 (HSP70) has been shown to be an inhibitor of apoptosis (Calderwood, Xie, 
Wang, 2010). As seen in Graph 2b, the HSP-70 was down-regulated when the Cal 27 
cells were treated with RSV.  Insulin-like growth factor 2 (IGF-II) is a protein 
structurally similar to insulin and it has been suggested that IGF-II enhances apoptosis in 
osteoblasts (Gronowicz, McCarthy, Zhang, & Zhang, 2004). We found that RSV up-
regulates IGF-II in Cal 27 cells. 
 
Graph 2b In this panel, changes  in HSP70, and IGF-11. 
 
Cyclin-dependent kinase inhibitor 21 (p21) and tumor suppressor P53 are two 
important factors in promoting cell cycle arrest and senescence (Harper, Adami, Wei, 
Keyomarsi, & Elledge, 1993).  They play vital roles in ensuring that the cell cycle will 
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not continue unchecked.  Both p53 and p21 levels were up-regulated by RSV.  In 
addition, SMAC (small mitochondria-derived activator of caspase) is a mitochondrial 
protein and leaks to the cytoplasm only when the mitochondrial membrane permeability 
increased.  In the cytoplasm, SMAC binds IAP (inhibitor of apoptosis) and prevent IAPs 
from arresting the apoptotic process and therefore allowing apoptosis to proceed 
(McNeish et al., 2003). As seen in Graph 2c, when the Cal 27 cells were treated with 
RSV the levels of p53, p21, and SMAC increased significantly. 
 
Graph 2c This panel shows changes in p21, p53, and SMAC 
 
Survivin and XIAP are the members of the large IAP family and both of them 
function to inhibit caspase activation and subsequently inhibit apoptosis (Sah, Khan, 
Khan, & Bisen, 2006).  Survivin is highly expressed in most human tumors and fetal 
tissues, but is completely absent in terminally differentiated cells (Sah, Khan, Khan, & 
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Bisen, 2006). As seen in Graph 2d, the level of survivin in the untreated cells is high but 
down-regulated by RSV.  XIAP like survivin is an anti-apoptosis protein, and in our 
experiment, XIAP, unlike survivin, showed, counter intuitively, an increase after 
treatment with RSV.  
 
Graph 2d This panel shows changes in survivin and XIAP. 
 
 
RSV activating caspase-3 and inducing PARP cleavage 
Western blot analyses were performed to determine whether caspase 3 activation 
and PARP cleavage were induced in CAL 27 cells in response to RSV. The cleaved 
Caspase-3 product was undetectable in the control, but a clear Caspase-3 cleavage 
product (89 kD) was present in the RSV-treated cells.  Activated caspase-3 cleaves DNA 
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and various proteins, including PARP (Gobeil, Boucher, Nadeau, & Poirier, 2001).  Then 
we conducted western blot using antibody against PARP.  The anti-body against PARP 
was able to detect both the full-length and the cleaved PARP (Figure 6).   The full-length 
PARP protein (116 kD) bands relative density decreased as the concentration of RSV 
increased.  On the other hand, the cleaved PARP product is readily detectable when the 
cells were treated with RSV at 100μM or higher concentrations.  
 
 
Figure -5 Activated Caspase-3 protein was not present when the cells were not treated with RSV. Addition 
of 200uM of RSV caused a band. Actin is present as a control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-6. RSV induces cleavage of PARP in Cal27 cells. CAL 27 cells were treated with the indicated 
doses of RSV for 24 hours. 10ug of whole cell lysate was separated and transferred to a nitrocellulose 
membrane. PARP Antibody detects endogenous levels of full length PARP (116 kDa), as well as the large 
fragments (89 kDa) of PARP resulting from caspase cleavage. The antibody does not cross-react with 
related proteins or other PARP isoforms. (Cell-Signaling Cat#9452) 
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Discussion 
Over the last decade, medicine has made a shift from reactive medicine to 
proactive medicine. The overall goal of proactive medicine is to assess ways to prevent 
diseases before they reach the point where the only treatment available is invasive, time 
consuming, financially burdensome, and potentially dangerous to the patient.  RSV has 
been shown to slow down and stop various cancer cell lines from dividing indefinitely in 
vitro (Anand et al., 2008). Although other natural products have been proven to be useful 
in tongue cancer prevention (Tanaka, et al. 2012), there was only one available report 
about the effects of RSV on HNSCC (Tyagi, Takahata 2011), and this research focused 
specifically on the relationship between RSV and SMAD4, a transcription factor. In this 
experiment, Tyagi et al. looked at RSV causing apoptosis in CAL 27 cells through only a 
specific SMAD4 pathway and did not elucidate a protein pathway of apoptosis. To our 
knowledge, report presented here is the first systematic analysis of RSV-induced protein 
expression profile in the tongue cancer cell line CAL 27.  Additionally, RSV has not been 
studied as a treatment of adenosquamous cancer of the oral cavity. The goal of these 
studies was to determine if RSV would lead to apoptosis and induce cancer cell death in 
these oral cancer cells and to identify various protein markers in RSV-induced apoptosis.   
The Annexin V assay is a widely used assay to show loss of cell membrane 
integrity. Phosphatidylserine (PS), translocation appears to be a universal apoptotic 
phenomenon observed in mammalian, insect, and plant cells under the action of most, if 
not all, triggers of apoptosis (Koopman et al., 1994). It binds preferentially to 
phospholipid species such as PS, which is normally absent in the outer leaflet of the 
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plasma membrane and shows minimal binding to phospholipid species such as 
phosphatidylcholine and sphingomyeline, which are constitutively present in the outer 
leaflet of plasma membranes. Necrosis, on the other hand, is accompanied by loss of cell 
membrane integrity and leakage of cellular constituents into the environment. The 
purpose of this experiment is to show that RSV is inducing the apoptotic process in Cal-
27 cancer cells. As shown in the results section, we were able to see fluorescence, 
suggesting that RSV was causing Cal-27 cell membrane integrity loss and thus, initiation 
of the apoptotic pathway. The experiment was done in a dose and time dependent 
manner. We chose 3 hour and 24 hour time periods to observe both early and late 
changes RSV caused in the cells. We also chose 0, 25, 50, 100 and 200μM of RSV to 
observe the effect of various concentrations of RSV on the cells.  The control group for 
both 3 hour and 24 hours showed little to no annexin fluorescence, suggesting that the 
cell membrane of these cells was not changed. As the concentration was increased, both 
time points showed increasingly higher levels of fluorescence suggesting that a higher 
level on annexin was being bound to the PS as the apoptosis was initiated by RSV.  Due 
to the fact that we can also see intact cell membranes by light microscope on the left 
panels on Figure 2a and 2b, it is reasonable to assume that there was no necrosis taking 
place, as in necrosis the cell membrane immediately loses its integrity and becomes leaky 
and a the florescence would not be in the circular pattern mimicking the intact cell 
membrane displayed on the right panels on figure 2a and 2b. Translocation of PS to the 
external cell surface, however, is not unique to apoptosis and also occurs during necrosis. 
The difference, though, between these two forms of cell death is that during the initial 
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stages of apoptosis the cell membrane remains intact, while in necrosis the cell membrane 
immediately loses its integrity and becomes leaky (BD Pharmingen, 2008). 
 During apoptosis, there are various protein markers that are up- or down-
regulated in order to either help the cell continue with apoptosis or alternatively to 
promote survival. When a cell is going through apoptosis, various pro-apoptotic markers 
are up-regulated and anti-apoptotic proteins are down-regulated.  Due to the vast amount 
of markers, we used an apoptosis protein array which detect up to 43 protein markers in 
one experiment. We used 2 plates of cells, one treated with 200μM of RSV and the other 
acting as a control. We loaded an equal amount of protein onto the membrane, developed 
the film and subsequently performed densitometry to compare the relative densities of the 
proteins and graphed the results. As seen in the results section graph 2a to 2d, there were 
many apoptosis markers that had a substantial change (defined as 1 unit change). These 
markers included caspase-8, CD-40, CD-40L, HSP-70, IGF-II, p21, p53, SMAC, 
survivin, and XIAP.  The other markers were not changed significantly due to a number 
of reasons, one of them being the fact that markers work through different pathways and 
cascades and at different time points. In our experiment, 10 of the 43 markers showed 
significant change with 200μM of RSV.  Although, we did not specifically focus on 
pathways, in the future, a good way of explaining these 10 markers would be in a manner 
that shows the cascade in a chronological order with more certainty than we can infer 
with our results. For example, we cannot say with certainty that resveratrol caused 
apoptosis only through an intrinsic or extrinsic pathway or a combination of both.  In the 
future, it would also be a good idea to repeat this experiment multiple times to get 
statistically significant changes for each apoptosis marker. 
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Caspase-8 is a cysteine-aspartic acid protease. Caspase-8 exists as a proenzyme 
and once cleaved is activated into an active caspase, activating on other executioner 
caspases i.e. caspase 3 and caspase 6. In normal cells, TNF-alpha and SMAC can activate 
caspase 8 and thus initiate apoptosis (Cohen, 1997). Looking at the graph 2a, we can see 
that the untreated Cal-27 cells have a baseline level of caspase-8, and once treated with 
RSV the relative amount of caspase-8 increases nearly three times. RSV, therefore, is 
likely activating either the intrinsic or extrinsic pathways or a combination of both to 
increase caspase-8. 
Studies done on cancers such as breast cancer and Hodgkin’s lymphoma have 
shown that the interaction of CD40 receptors with their ligand can reduce apoptosis 
through a caspase-3 dependent mechanism (Voorzanger-Rousselot, Alberti, & Blay, 
2006). CD40 and CD40L interaction has been shown to promote survival of the cell by 
increasing Bcl-X that in turn helps stop the release of cytochrome-c from the 
mitochondria and thus prevent the intrinsic pathway of apoptosis.  In an experiment, 
Rousselot et.al showed that cancer cells that expressed CD40L are more resistant to 
cytotoxic agents and cell death. In their experiment, both breast cancer cells and NHL 
cell lines that were co-cultured with CD40L considerably reduced (from 23-62 percent) 
apoptosis when cells were treated with anti-cancer drugs (Voorzanger-Rousselot, Alberti, 
& Blay, 2006).  In our experiment, we saw that CD40 and CD40L were downregulated 
when treated with RSV. This suggests that similar to breast cancer and NHL cells RSV 
inhibits the anti-apoptotic mechanism in CAL-27 cells.  
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Heat shock proteins are a family of ubiquitously expressed proteins that are an 
important part of cell’s machinery for protein folding and protection from stress. Heat 
shock protein-70 (HSP70) has been shown to be an inhibitor of apoptosis. Li et al showed 
that addition of purified recombinant HSP70 to normal cytosol prevented the cleavage of 
caspase-3 and DNA fragmentation and thus prevented apoptosis. In Cal-27 cells that 
were treated with RSV, we saw that HSP-70 was down regulated, again consistent with a 
decreased resistance to apoptosis (Li, Lee, Ko, Kim, & Seo, 2000).   
Insulin-like growth factor 2 (IGF-II), a protein hormone structurally similar to 
insulin, acts as a growth promoting hormone during gestation (Gronowicz, McCarthy, 
Zhang, & Zhang, 2004). Gornowic et.al studied the ability of IGF-II to modulate 
apoptosis in osteoblasts. Over expressed IGF-II produced a dose-dependent increase in 
apoptosis. In our experiment, when the Cal-27 cells were treated with RSV, we saw an 
increase in IGF-II correlating with the increase in apoptosis. Cyclin-dependent kinase 
inhibitor 1 (p21) is a protein that is encoded by CDKN1A gene located on chromosome 
6. P21 binds and inhibits CDK thus promoting cell cycle arrest in response to DNA 
damage or any other stressors that require the cell to go through senescence. If p21 is not 
working correctly or is inhibited, the cell cycle can continue unchecked, which can 
subsequently contribute to cancer (Harper, Adami, Wei, Keyomarsi, & Elledge, 1993). In 
Cal-27 cells treated with RSV, we saw that the p21 level was increased, consistent with 
RSV inhibition of cell proliferation. 
P53 is a tumor suppressor protein that regulates cell the cycle in part by inducing 
p21. In addition, it can also trigger apoptosis in response to DNA damage by activating 
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both the intrinsic and extrinsic pathway of apoptosis. P53 controls transcription of 
proapoptotic members of the Bcl-2 family. It can also activate caspase-9 which helps 
initiate apoptosis.  Its function is vital in ensuring that the cell cycle does not go 
unchecked and thus, preventing cancer (Fridman & Lowe, 2003).  When Cal-27 cells 
were treated with RSV p53 is upregulated, which again is consistent with RSV inhibition 
of the cell proliferation and induction of apoptosis. 
SMACs (small mitochondria-derived activator of caspase) are mitochondrial 
proteins and released into the cytosol following an increase in membrane permeability. 
SMAC binds to inhibitor of apoptosis (IAPs) and deactivates them, preventing the IAPs 
from arresting the apoptotic process and therefore allowing apoptosis to proceed.  IAP 
also normally suppresses the activity of caspases that degrade the cell (McNeish et al., 
2003). When Cal-27 cells were treated with RSV, SMAC protein levels increased, 
consistent with RSV induced apoptosis through this pathway. Survivin and XIAP are a 
family of inhibitors of apoptosis (IAP). Survivin, and to a greater degree, XIAP function 
to inhibit caspase activation which helps negatively regulate apoptosis.  The survivin 
protein is expressed highly in most human tumors and fetal tissue, but is completely 
absent in terminally differentiated cells.
 
This makes survivin an ideal target for cancer 
therapy. Survivin expression is also highly regulated in the cell cycle and is only 
expressed in the G2-M phase. It is known that survivin localizes to the mitotic spindle by 
interaction with tubulin during mitosis and may play a contributing role in regulating 
mitosis (Sah, Khan, Khan, & Bisen, 2006).  When the Cal-27 cells were treated with 
RSV, we saw that survivin was downregulated, suggesting that RSV works in a way that 
reduces the production of the survivin protein which would to help the cell undergo 
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apoptosis. However, the one discrepancy seen in the proteins that showed a large change 
in the human apoptosis assay was the increase in XIAP with the treatment of RSV. Like 
survivin, we would assume that XIAP would also be downregulated if the cells were 
attempting to undergo apoptosis. One of the explanations for this increase is the fact that 
XIAP is a very strong IAP and when there is a chemical that will cause apoptosis of the 
cell, XIAP will begin to increase its production as a last ditch effort to protect the cell 
from death (Deveraux, Quinnand, 1999).   
There are many advantages of using an apoptosis array such as its relatively rapid 
assessment of apoptotic proteins. It is also relatively economical, and has a high 
sensitivity; however, there are also some caveats. Although sensitive, it is not very 
specific. In order to confirm the results obtained from the apoptosis array, we need a 
more specific test such as a western blot. In order to do this we picked 2 protein markers 
that have either been historically vital in apoptosis or were upregulated in our apoptosis 
array. The first marker we chose was caspase-3, which is the active protease, arising from 
the zymogen form, which translocates into the nucleus and cleaves DNA and other 
various proteins such as PARP within the nucleus to cause cell death. In western blot 
analysis (Figure 5) we can see that when the Cal-27 cells were not treated with RSV (in 
the control group) activated caspase-3 was not detected.  However, when the cells were 
treated with 200μM of RSV, there was an increase in caspase-3 protein which could 
occur through various different mechanisms (Figure 5). It is reasonable to conclude that 
through the action of RSV the Cal-27 cancer cells activate caspase-3 to initiate apoptosis 
and cause cell death. 
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The other protein we choose was PARP. PARP is an ideal protein to look at 
because the anti-body we used is able to detect not only the full length PARP but also the 
large cleaved products. Detecting full length and cleaved products differentiates between 
cells that have been acted on by RSV and are undergoing apoptosis and cells that have 
not been acted on by RSV and are not undergoing apoptosis.  It can also further 
substantiate the presence of the activated caspase-3, since caspase-3 is a protease that 
cleaves PARP.  As we can see in Figure 6, as the concentration of RSV increased, the full 
length PARP protein (116 kD) decreased, suggesting that with higher levels of RSV there 
was cleavage of PARP.  The cleaved PARP products (89 kD) were constitutively present 
with lower levels of RSV (25μM), but as the RSV concentration increased and more 
cleavage of PARP occurred, we started to see an increase in protein levels for the cleaved 
PARP, suggesting that PARP was getting cleaved in response to RSV.  The constitutive 
level of cleaved PARP when the cells were not treated with RSV is one of the 
confounding variables that don’t seem to have a good explanation for. Although, we 
would expect any cell to have some levels as the cells go through cell death, why there is 
such a high level is something that needs to be explored in future studies.  
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Implications and Future studies 
Our hope was to increase knowledge of oral cancer, resveratrol and more 
generally, natural product treatment option for cancer. As stated previously, the current 
information pertaining to oral cancer and resveratrol is lacking. Numerous studies in oral 
cancer show that various oral cancer cell lines work in different ways and the closest 
model to the oral squamous cancer cell (OSCC) line is the Cal-27 cell line. Our goal, 
which we were successful in achieving, was to show that resveratrol causes apoptosis of 
Cal-27 cells. Having this knowledge sheds light not only on this specific tongue cancer 
cell line, but also, more generally on any cancer cell lines that work in a similar fashion. 
We acknowledge that in the pharmaceutical world, 28,000 new cases of oral cancer is not 
exactly the most profitable venture to invest in, but the addition of 28,000 new cases on 
top of the other cancer that RSV already works on would be substantial. The knowledge 
that RSV causes cell death in this cancer cell line with an idea of the specific protein 
markers targeted with RSV,  will further help establish a stronger and more specific 
treatment regimen for each individual patient.   
From the experiments conducted in this research we found that RSV is indeed 
causing apoptosis of Cal-27 cells. Future studies should seek to further elucidate the 
pathway RSV uses to accomplish. If the specific pathway RSV uses can be illustrated, we 
can further understand the mechanism of oral cancer and how exactly RSV interferes 
with this pathway, making the treatment of oral cancer more specific, more targeted and 
faster.   
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